CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 4, 2013, Pages 360-366

  Guaraldi, Giovanni ^a   Luzi, Kety ^b   Bellistrì, Giusi Maria ^b   Zona, Stefano ^a   Da Silva, Ana Rita Domingues ^c   Bai, Francesca ^b   Garlassi, Elisa ^a   Marchetti, Giulia ^b   Capeau, Jacqueline ^d   Antonella, D'Arminio Monforte ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Hospital de Joaquim Urbano   (Portugal)

^d HÔPITAL TENON   (France)

Author keywords

aging; immunactivation; lipodistrophy

Indexed keywords

ADP RIBOSYL CYCLASE/CYCLIC ADP RIBOSE HYDROLASE 1; CD4 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; STAT5 PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; CARDIOVASCULAR RISK; CD8+ T LYMPHOCYTE; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; CYTOMETRY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID STORAGE; LIPOATROPHY; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ADIPOSE TISSUE; GENETICS; HIV ASSOCIATED LIPODYSTROPHY; HIV INFECTIONS; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; PHYSIOLOGY; VIREMIA; VIRUS LOAD;

ADIPOSE TISSUE; ADULT; ANTI-HIV AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHOSPHORYLATION; STAT5 TRANSCRIPTION FACTOR; VIRAL LOAD; VIREMIA;

EID: 84885337387     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000001     Document Type: Article

References (38)

1. Caron-Debarle M, Boccara F, Lagathu C, et al. Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations. Curr Pharm Des. 2010;16:3352-3360.
2. Leclercq P, Goujard CMD, Duracinsky M, et al. High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy. AIDS Res Hum Retroviruses. 2013;29:761-768.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444:860-867.
4. Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914-920.
5. Viardot A, Heilbronn LK, Samocha-Bonet D, et al. Obesity is associated with activated and insulin resistant immune cells. Diabetes Metab Res Rev. 2012;28:447-454.
6. Duffaut C, Zakaroff-Girard A, Bourlier V, et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol. 2009;29:1608-1614.
7. Yang H, Youm YH, Vandanmagsar B, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: Implications for systemic inflammation and insulin resistance. J Immunol. 2010;185:1836-1845.
8. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108: 2460-2466.
9. Rabkin SW. Epicardial fat: Properties, function and relationship to obesity. Obes Rev. 2007;8:253-261.
10. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis. 2011;203:452-463.
11. Paiardini M, Cervasi B, Albrecht H, et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol. 2005;174:2900-2909.
12. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203: 780-790.
13. Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308:379-386.
14. Lang S, Mary-Krause M, Simon A, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012;55:600-607.
15. Orlando G, Guaraldi G, Zona S, et al. Ectopic fat is linked to prior cardiovascular events in men with HIV. J Acquir Immune Defic Syndr. 2012;59:494-497.
16. Crum-Cianflone N, Krause D, Wessman D, et al. Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons. HIV Med. 2011;12:463-471.
17. Brown TT, Xu X, John M, et al. Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: A substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther. 2009;6:8.
18. Guaraldi G, Zona S, Garlassi E, et al. Body Composition changes in ageing HIV infected patients: The complex interplay between low muscle mass, lipodystrophy and osteopenia. Antivir Ther. 2012;17:A30-A31.
19. Capeau J, Bouteloup V, Katlama C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS. 2012;26:303-314.
20. Samaras K. Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;50:499-505.
21. Boccara F, Lang S, Meuleman C, et al. HIV and coronary heart disease: Time for a better understanding. J Am Coll Cardiol. 2013;61:511-523.
22. Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614-622.
23. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001; 15:1389-1398.
24. Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
25. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743-753.
26. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
27. Guaraldi G, Stentarelli C, Zona S, et al. Lipodystrophy and antiretroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis. 2010;208: 222-227.
28. Snyder S, Cheng B, Miller V. Regulatory Considerations for the Treatment of Lipodystrophy. Ann Forum Collaborative HIV Res (Forum Ann). 2005;7:1-44.
29. Hammond E, McKinnon E, Nolan D. Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: Prevalence and metabolic consequences. Clin Infect Dis. 2010;51:591-599.
30. Benito JM, Lopez M, Lozano S, et al. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2005;38:373-381.
31. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371.
32. Marchetti G, Cozzi-Lepri A, Merlini E, et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS. 2011;25:1385-1394.
33. Hunt PW, Brenchley J, Sinclair E, et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197:126-133.
34. Gress RE, Deeks SG. Reduced thymus activity and infection prematurely age the immune system. J Clin Invest. 2009;119:2884-2887.
35. Sauce D, Larsen M, Fastenackels S, et al. HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood. 2011;117:5142-5151.
36. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis. 2011;217:207-213.
37. Bellistri GM, Casabianca A, Merlini E, et al. Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapy. PLoS One. 2010;5:e15663.
38. Camargo JF, Kulkarni H, Agan BK, et al. Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. J Infect Dis. 2009;199:1872-1882.